Discovery of novel anti-infective agents.

Non-profit antibacterial antiparasitic antiviral coronavirus global health lead optimization long acting injectables medicinal chemistry tuberculosis

Journal

Advances in pharmacology (San Diego, Calif.)
ISSN: 1557-8925
Titre abrégé: Adv Pharmacol
Pays: United States
ID NLM: 9015397

Informations de publication

Date de publication:
2024
Historique:
medline: 22 7 2024
pubmed: 22 7 2024
entrez: 21 7 2024
Statut: ppublish

Résumé

Academic and other non-profit institutions have a long-term vision to improve human health where commercial interests can be limited for profit organizations. Medicinal chemistry to these diseases with no commercial benefit needs is well suited in the academic environment and this chapter outlines some work conducted at Calibr-Skaggs around antibiotic drug development that has led to initiation of multiple clinical trials over the last decade.

Identifiants

pubmed: 39034055
pii: S1054-3589(24)00016-4
doi: 10.1016/bs.apha.2024.05.001
pii:
doi:

Substances chimiques

Anti-Infective Agents 0
Anti-Bacterial Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

39-117

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Arnab K Chatterjee (AK)

Calibr-Skaggs Institute of Innovation Medicines, Scripps Research, La Jolla, CA, United States. Electronic address: achatterjee@scripps.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH